The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression V Van den Eynde, WR Abdelmoemin, MM Abraham, JD Amsterdam, ... CNS spectrums 28 (4), 427-440, 2023 | 30 | 2023 |
The Prescriber’s guide to the MAOI diet—thinking through tyramine troubles V Van den Eynde, PK Gillman, BB Blackwell Psychopharmacology Bulletin 52 (2), 73, 2022 | 18 | 2022 |
The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors V Van den Eynde Journal of Neural Transmission 128 (11), 1741-1756, 2021 | 7 | 2021 |
Monoamine Oxidase Inhibitors and Clinically Relevant Drug Interactions: A Guide for Preventing Serotonin Toxicity and Hypertensive Reactions PK Gillman, V Van den Eynde, L Godet, C Redhead, A Horwitz, B Barnett Psychiatric Annals 53 (8), 353-358, 2023 | 2 | 2023 |
The larger than linear effect of high-dose tyramine on systolic blood pressure–the MAOI diet modified V Van den Eynde, PK Gillman International Journal of Psychiatry in Clinical Practice 24 (3), 328-328, 2020 | 2 | 2020 |
On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic Depression. V Van den Eynde, G Parker, HG Ruhé, TK Birkenhäger, L Godet, ... Psychopharmacology bulletin 53 (3), 35-54, 2023 | 1 | 2023 |
An expert roundtable discussion on the use of classic monoamine oxidase inhibitors in the treatment of depression–part two M Berk, V Van den Eynde, K Ganapathy, C Andrade, T Birkenhäger, ... Psychiatric Annals 53 (8), 364-369, 2023 | 1 | 2023 |
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations F Rossano, C Caiazza, A Sobrino, N Solini, A Vellucci, N Zotti, M Fornaro, ... European Neuropsychopharmacology 72, 60-78, 2023 | 1 | 2023 |
Classic Monoamine Oxidase Inhibitors for Depression: Update on Nursing Care V Van den Eynde, L Godet, S Trupin, PK Gillman Issues in Mental Health Nursing 44 (2), 138-139, 2023 | 1 | 2023 |
Requiem or resurrection: Classic monoamine oxidase inhibitors revisited. V Van den Eynde, PK Gillman European Neuropsychopharmacology: the Journal of the European College of …, 2022 | 1 | 2022 |
SOLK bij jongeren: naar een uniforme begripsafbakening? V Van den Eynde Kind en adolescent 41 (4), 385-388, 2020 | 1 | 2020 |
Classics in Chemical Neuroscience: Selegiline, Isocarboxazid, Phenelzine, and Tranylcypromine GR Hoffman, MG Olson, AM Schoffstall, RF Estévez, V Van den Eynde, ... ACS Chemical Neuroscience 14 (23), 4064-4075, 2023 | | 2023 |
Monoamine Oxidase Inhibitor Interactions: An Addendum to Dr Shader's Letter PK Gillman, V Van den Eynde Journal of Clinical Psychopharmacology 43 (6), 554, 2023 | | 2023 |
A five‐pronged critique of ‘Serotonin syndrome—A focused review’ PK Gillman, V Van den Eynde, C Redhead Basic & Clinical Pharmacology & Toxicology 133 (5), 548-549, 2023 | | 2023 |
Monoamine Oxidase Inhibitors and Clinically Relevant Drug Interactions: A Guide for Preventing Serotonin Toxicity and Hypertensive Reactions V Van den Eynde, L Godet, C Redhead, A Horwitz, B Barnett Psychiatric Annals 53 (8), 353-358, 2023 | | 2023 |
MAOIs: Reconsideration and Re-education V Van den Eynde Psychiatric Annals 53 (8), 343-344, 2023 | | 2023 |
MAOIs: Reconsideration and Re-education PK Gillman, V Van den Eynde Psychiatric Annals 53 (8), 343-344, 2023 | | 2023 |
An Expert Roundtable Discussion on the Use of Classic Monoamine Oxidase Inhibitors in the Treatment of Depression–Part One A Young, J Rucker, V Van den Eynde, C Redhead, B Barnett, L Godet, ... Psychiatric Annals 53 (8), 359-363, 2023 | | 2023 |
The Pocket Guide to Classic Monoamine Oxidase Inhibitors for Treatment-Resistant Depression S Stahl, V Van den Eynde, L Godet, C Redhead, PK Gillman Psychiatric Annals 53 (8), 347-352, 2023 | | 2023 |
Causality is the missing key: A comment on the history of MAOIs and RCTs V Van den Eynde, PK Gillman Journal of affective disorders 319, 670-671, 2022 | | 2022 |